C3 Glomerulopathy Latest Advances

Multimodal imaging of membranoproliferative glomerulonephritis type II.

Journal: Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society

Published: April 03, 2015

Treatment of choroidal neovascularisation secondary to membranoproliferative glomerulonephritis type II with intravitreal ranibizumab.

Journal: BMJ case reports

Published: June 05, 2014

High-speed ultrahigh-resolution OCT of Bruch's membrane in membranoproliferative glomerulonephritis type 2.

Journal: Ophthalmic surgery, lasers & imaging retina

Published: February 12, 2014

Membranoproliferative glomerulonephritis, type II cryoglobulinemia and triple therapy for hepatitis C: a case series and review of the literature.

Journal: Digestive diseases and sciences

Published: November 06, 2013

Gene polymorphism of complement factor H in a Turkish patient with membranoproliferative glomerulonephritis type II.

Journal: Iranian journal of kidney diseases

Published: July 03, 2011

Functional and morphological macular abnormalities in membranoproliferative glomerulonephritis type II.

Journal: The British journal of ophthalmology

Published: August 04, 2010

Treatment of subretinal neovascular membrane in a patient with membranoproliferative glomerulonephritis type II.

Journal: Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye

Published: July 29, 2009

Oligosaccharide composition is similar in drusen and dense deposits in membranoproliferative glomerulonephritis type II.

Journal: Kidney international

Published: January 30, 2009

Nephritic factor and recurrence in the renal transplant of membranoproliferative glomerulonephritis type II.

Journal: Pediatric nephrology (Berlin, Germany)

Published: January 06, 2008

Membranoproliferative glomerulonephritis type II (dense deposit disease) in association with monoclonal gammopathy.

Journal: Nephrology (Carlton, Vic.)

Published: July 20, 2007

Microperimetric evaluation of macula in retinopathy of membranoproliferative glomerulonephritis type II: a case report.

Journal: European journal of ophthalmology

Published: September 05, 2006

Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).

Journal: Journal of medical genetics

Published: November 22, 2005

C3 Glomerulopathy Latest Advances

Find the Latest Research About C3 Glomerulopathy

Multimodal imaging of membranoproliferative glomerulonephritis type II.

Multimodal imaging of membranoproliferative glomerulonephritis type II.

Treatment of choroidal neovascularisation secondary to membranoproliferative glomerulonephritis type II with intravitreal ranibizumab.

Treatment of choroidal neovascularisation secondary to membranoproliferative glomerulonephritis type II with intravitreal ranibizumab.

High-speed ultrahigh-resolution OCT of Bruch's membrane in membranoproliferative glomerulonephritis type 2.

High-speed ultrahigh-resolution OCT of Bruch's membrane in membranoproliferative glomerulonephritis type 2.

Membranoproliferative glomerulonephritis, type II cryoglobulinemia and triple therapy for hepatitis C: a case series and review of the literature.

Membranoproliferative glomerulonephritis, type II cryoglobulinemia and triple therapy for hepatitis C: a case series and review of the literature.

Gene polymorphism of complement factor H in a Turkish patient with membranoproliferative glomerulonephritis type II.

Gene polymorphism of complement factor H in a Turkish patient with membranoproliferative glomerulonephritis type II.

Functional and morphological macular abnormalities in membranoproliferative glomerulonephritis type II.

Functional and morphological macular abnormalities in membranoproliferative glomerulonephritis type II.

Treatment of subretinal neovascular membrane in a patient with membranoproliferative glomerulonephritis type II.

Treatment of subretinal neovascular membrane in a patient with membranoproliferative glomerulonephritis type II.

Oligosaccharide composition is similar in drusen and dense deposits in membranoproliferative glomerulonephritis type II.

Oligosaccharide composition is similar in drusen and dense deposits in membranoproliferative glomerulonephritis type II.

Nephritic factor and recurrence in the renal transplant of membranoproliferative glomerulonephritis type II.

Nephritic factor and recurrence in the renal transplant of membranoproliferative glomerulonephritis type II.

Membranoproliferative glomerulonephritis type II (dense deposit disease) in association with monoclonal gammopathy.

Membranoproliferative glomerulonephritis type II (dense deposit disease) in association with monoclonal gammopathy.

Microperimetric evaluation of macula in retinopathy of membranoproliferative glomerulonephritis type II: a case report.

Microperimetric evaluation of macula in retinopathy of membranoproliferative glomerulonephritis type II: a case report.

Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).

Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).